Simon Kraler

1.7k citations
48 papers · 777 · 1 hit paper · h-index 14

Impact in

Papers in

Simon Kraler

40 papers receiving 763 citations

Simon Kraler's Hit Papers

SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits 2024 · 53 citations
530+1Years since publication1020304050

Peers

Simon Kraler
Comparison fields: 5 of 88
  • Cardiology and Cardiovascular Medicine 364
  • Geriatrics and Gerontology 25
  • Immunology 135
  • Health Informatics 6
  • Endocrinology, Diabetes and Metabolism 66
Replace Adam Nabeebaccus with:
Adam Nabeebaccus United Kingdom
Chien‐Sung Tsai Taiwan
Yun Ti China
Paola Vallerio Italy
Shi Tai China
Stefania Momi Italy
Yangjing Xue China
Spyridon Simantiris Greece
Antonio Moscardó Spain
Michael Basso United States
Simon Kraler relative to Adam Nabeebaccus United Kingdom Adam Nabeebaccus's profile →
Citations per field
00.5×3.9×
Adam Nabeebaccus · 1×
Citations per year

Countries citing papers authored by Simon Kraler

Since Specialization
Citations

This map shows the geographic impact of Simon Kraler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Kraler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Kraler more than expected).

Fields of papers citing papers by Simon Kraler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Kraler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Kraler. The network helps show where Simon Kraler may publish in the future.

Co-authors

The 25 scholars most cited alongside Simon Kraler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Simon Kraler Line = papers co-authored together Simon Kraler links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2021128
2 2020106
3 202163
4 202160
5 202258
6
SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits
Hit paper breakdown →
202453
7 202234
8 202130
9 202129
10 202327
11 202324
12 202021
13 202314
14 202213
15 202512
16 202211
17 202310
18 202310
19 20259
20 20239

About Simon Kraler

Simon Kraler is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Immunology, Physiology and Molecular Biology, having authored 48 papers that have together received 777 indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (10 papers), Atherosclerosis and Cardiovascular Diseases (9 papers), Sirtuins and Resveratrol in Medicine (6 papers), Coronary Interventions and Diagnostics (6 papers), Cardiac Imaging and Diagnostics (5 papers), Heart Failure Treatment and Management (5 papers), Lipoproteins and Cardiovascular Health (5 papers) and Antioxidant Activity and Oxidative Stress (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (364 citations), Geriatrics and Gerontology (25 citations), Immunology (135 citations), Health Informatics (6 citations) and Endocrinology, Diabetes and Metabolism (66 citations). Simon Kraler has collaborated with scholars based in Switzerland, United Kingdom and Italy. Frequent co-authors include Thomas F. Lüscher, Giovanni G. Camici, Elena Aïkawa, Mark C. Blaser, Alexander Akhmedov, Luca Liberale, Chu‐Huang Chen, Florian A. Wenzl, Daria Vdovenko and Tatsuya Sawamura. Their work appears in journals such as European Heart Journal, European Journal of Clinical Investigation, Cardiovascular Research, International Journal of Cardiology and Atherosclerosis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact